Access the full text.
Sign up today, get DeepDyve free for 14 days.
Franz Recker, M. Kwiatkowski, T. Piironen, Kim Pettersson, Andreas Huber, Gerd Lümmen, Reto Tscholl (2000)
Human glandular kallikrein as a tool to improve discrimination of poorly differentiated and non-organ-confined prostate cancer compared with prostate-specific antigen.Urology, 55 4
J. McNeal, A. Villers, E. Redwine, F. Freiha, T. Stamey (1990)
Histologic differentiation, cancer volume, and pelvic lymph node metastasis in adenocarcinoma of the prostateCancer, 66
C. Becker, T. Piironen, Kim Pettersson, T. Björk, K. Wojno, J. Oesterling, Hans Lilja (2000)
Discrimination of men with prostate cancer from those with benign disease by measurements of human glandular kallikrein 2 (HK2) in serum.The Journal of urology, 163 1
(1977)
Histologic grading and clinical staging of prostatic carcinoma
M. Graefen, A. Haese*, U. Pichlmeier, P. Hammerer, J. Noldus, K. Butz, A. Erbersdobler, R. Henke, U. Michl, S. Fernandez, H. Huland (2001)
A validated strategy for side specific prediction of organ confined prostate cancer: a tool to select for nerve sparing radical prostatectomy.The Journal of urology, 165 3
A. Partin, M. Kattan, E. Subong, P. Walsh, K. Wojno, J. Oesterling, P. Scardino, J. Pearson (1997)
Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update.JAMA, 277 18
L. Sobin, F. Greene (2001)
TNM classificationCancer, 92
A. Partin, W. Catalona, J. Finlay, Claude Darte, Donald Tindall, Charles Young, George Klee, Daniel Chan, Harry Rittenhouse, R. Wolfert, D. Woodrum (1999)
Use of human glandular kallikrein 2 for the detection of prostate cancer: preliminary analysis.Urology, 54 5
A. Haese, C. Becker, J. Noldus, M. Graefen, Edith Huland, H. Huland, Hans Lilja (2000)
Human glandular kallikrein 2: a potential serum marker for predicting the organ confined versus non-organ confined growth of prostate cancer.The Journal of urology, 163 5
M. Kwiatkowski, F. Recker, T. Piironen, Kim Pettersson, Thomas Otto, Martin Wernli, Reto Tscholl (1998)
In prostatism patients the ratio of human glandular kallikrein to free PSA improves the discrimination between prostate cancer and benign hyperplasia within the diagnostic "gray zone" of total PSA 4 to 10 ng/mL.Urology, 52 3
(1977)
Urologic pathology: The prostate. Chap. 9. Philadelphia: Lea & Ferbiger
R. Lahtonen, N. Bolton, R. Vihko, M. Kontturi (1983)
Nuclear androgen receptors in the epithelium and stroma of human benign prostatic hypertrophic glandsThe Prostate, 4
J. Finlay, C. Evans, J. Day, J. Payne, S. Mikolajczyk, L. Millar, K. Kuus-Reichel, R. Wolfert, H. Rittenhouse (1998)
Development of monoclonal antibodies specific for human glandular kallikrein (hK2): development of a dual antibody immunoassay for hK2 with negligible prostate-specific antigen cross-reactivity.Urology, 51 5
F. Schröder, P. Hermanek, L. Denis, W. Fair, M. Gospodarowicz, M. Pavone‐Macaluso (1992)
The TNM classification of prostate cancerThe Prostate, 21
C. Becker, T. Piironen, J. Kiviniemi, H. Lilja, K. Pettersson (2000)
Sensitive and specific immunodetection of human glandular kallikrein 2 in serum.Clinical chemistry, 46 2
(2000)
Value ofmolecular forms of prostate specific antigen and related kallikrein, hK2, in diagnosis and staging of prostate cancer
Background In recent studies serum levels of human glandular kallikrein 2 (hK2) demonstrated significant differences in pathologically organ‐confined versus non‐organ‐confined prostate cancer (PCa). In this study we investigated whether hK2 adds independent information when considered together with traditionally used parameters to predict organ confined (pT2a/b) PCa. Methods Serum levels of hK2, total and free prostate‐specific antigens (PSA) were obtained one day before radical prostatectomy in 245 consecutive men. These were included with clinical stage and biopsy Gleason grade into univariate analysis and multivariate logistic regression models. Results pT2a/b PCa was found in n = 148 patients. In univariate analysis all preoperative parameters demonstrated significant association with the presence of pT2a/b PCa. Using multivariate logistic regression model hK2 (P = 0.022), clinical stage (P < 0.0001), and Gleason grade (P < 0.0001) were independent predictors of pT2a/b PCa whereas PSA (P = 0.3) was not. In bootstrap corrected logistic regression based nomograms the addition of hK2 density marginally enhanced predictive accuracy when PSA, PSA density, clinical stage, and Gleason grade were considered (AUC = 0.879 without hK2 density and 0.883 with hK2 density). Conclusions hK2 and hK2 density could independently predict pT2a/b PCa. However, improvement in predictive accuracy was marginal when nomograms based on traditional variables were complemented with this serum marker. Prostate 54: 181–186, 2003. © 2002 Wiley‐Liss, Inc.
The Prostate – Wiley
Published: Feb 15, 2003
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.